We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-14.27%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$123B
AUM Growth
-$24.7B
(-17%)
Cap. Flow
-$418M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
30.06%
Holding
304
New
10
Increased
88
Reduced
149
Closed
13
Avg Time Held
3.8
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$485M |
| 2 |
Hess
HES
|
+$460M |
| 3 |
Wells Fargo
WFC
|
+$356M |
| 4 |
Albemarle
ALB
|
+$291M |
| 5 |
Linde
LIN
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$468M |
| 2 |
Dell
DELL
|
+$283M |
| 3 |
Adobe
ADBE
|
+$261M |
| 4 |
Praxair Inc
PX
|
+$231M |
| 5 |
NetApp
NTAP
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 25.96% |
| 3 | Industrials | 15.66% |
| 4 | Financials | 9.32% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Alkermes
ALKS
$6.73B
| $687M | 0.56% |
23,280,730
+7,672
| +0% | +$283K |
2016 Q2
10 quarters
|
|
52
Medtronic
MDT
$122B
| $658M | 0.53% |
7,234,775
-246,220
| -3% | -$23M |
2013 Q2
22 quarters
|
|
53
Nektar Therapeutics
NKTR
$1.29B
| $638M | 0.52% |
1,293,335
-50,326
| -4% | -$30.4M |
2013 Q2
22 quarters
|
|
54
Flex
FLEX
$36.4B
| $587M | 0.48% |
102,439,436
+16,169,019
| +19% | +$113M |
2013 Q2
22 quarters
|
|
|
ETFC
55
DELISTED
E*Trade Financial Corporation
ETFC
| $585M | 0.47% |
13,335,725
+219,900
| +2% | +$10.8M |
2014 Q4
16 quarters
|
|
56
Aecom
ACM
$7.6B
| $570M | 0.46% |
21,512,734
+2,436,233
| +13% | +$74.1M |
2013 Q2
22 quarters
|
|
57
Qiagen
QGEN
$9.53B
| $547M | 0.44% |
14,983,993
-293,506
| -2% | -$10.9M |
2016 Q4
8 quarters
|
|
58
BlackBerry
BB
$5.11B
| $517M | 0.42% |
72,778,693
-950,100
| -1% | -$8.37M |
2013 Q2
22 quarters
|
|
59
Mattel
MAT
$4.95B
| $508M | 0.41% |
50,840,399
+96,770
| +0.2% | +$1.28M |
2017 Q2
6 quarters
|
|
60
Visa
V
$750B
| $508M | 0.41% |
3,849,039
-229,400
| -6% | -$31.7M |
2013 Q2
22 quarters
|
|
61
Analog Devices
ADI
$196B
| $498M | 0.4% |
5,800,124
+649,224
| +13% | +$56.2M |
2013 Q2
22 quarters
|
|
62
Bath & Body Works
BBWI
$4.12B
| $494M | 0.4% |
23,792,186
+10,141
| +0% | +$256K |
2013 Q2
22 quarters
|
|
63
Jacobs Solutions
J
$16.6B
| $481M | 0.39% |
9,951,784
-93,997
| -0.9% | -$5.37M |
2013 Q2
22 quarters
|
|
64
Corning
GLW
$119B
| $478M | 0.39% |
15,813,873
-239,050
| -1% | -$7.63M |
2013 Q2
22 quarters
|
|
65
Amazon
AMZN
$2.75T
| $470M | 0.38% |
6,253,560
+84,000
| +1% | +$6.98M |
2013 Q2
22 quarters
|
|
66
Universal Display
OLED
$3.6B
| $441M | 0.36% |
4,712,919
+1,636,616
| +53% | +$165M |
2014 Q3
17 quarters
|
|
67
Northern Trust
NTRS
$30.3B
| $407M | 0.33% |
4,863,737
+1,462,356
| +43% | +$137M |
2016 Q1
11 quarters
|
|
68
Honeywell
HON
$66.7B
| $400M | 0.32% |
3,210,644
-153,832
| -5% | -$21M |
2013 Q2
22 quarters
|
|
69
Insulet
PODD
$9.62B
| $387M | 0.31% |
4,876,258
-77,214
| -2% | -$6.53M |
2013 Q2
22 quarters
|
|
70
Boeing
BA
$149B
| $386M | 0.31% |
1,196,829
| – | – |
2013 Q2
22 quarters
|
|
|
ATVI
71
DELISTED
Activision Blizzard
ATVI
| $381M | 0.31% |
8,179,350
-175,200
| -2% | -$10.5M |
2013 Q2
22 quarters
|
|
72
CME Group
CME
$104B
| $378M | 0.31% |
2,010,943
-21,400
| -1% | -$3.95M |
2013 Q2
22 quarters
|
|
73
Oracle
ORCL
$408B
| $377M | 0.31% |
8,358,817
+139,200
| +2% | +$6.67M |
2013 Q2
22 quarters
|
|
74
Union Pacific
UNP
$172B
| $370M | 0.3% |
2,679,586
-101,001
| -4% | -$15M |
2013 Q2
22 quarters
|
|
75
JetBlue
JBLU
$1.19B
| $368M | 0.3% |
22,922,450
-43,375
| -0.2% | -$756K |
2013 Q2
22 quarters
|
|
Similar funds
Primecap Management's Q4 2018 Portfolio in Review
As of Q4 2018, Primecap Management held 304 positions worth $123B, down 17% from $148B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2018 filing shows 10 new, 88 increased, 149 reduced and 13 closed positions. Its largest new stake was Linde: 1,431,369 shares worth $223M. The largest sale was Eli Lilly, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2018 buy was Linde: 1,431,369 shares worth $223M.
- Primecap Management added most to Bank of America in Q4 2018, an estimated $485M increase.
- Primecap Management's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $468M.
- Primecap Management fully exited Praxair Inc in Q4 2018, selling an estimated $231M.
- Primecap Management's ten largest holdings make up 30% of its $123B portfolio in Q4 2018.
- Primecap Management opened 10 new positions and closed 13 in Q4 2018.
- Primecap Management's portfolio value fell 17% quarter-over-quarter to $123B.
Based on Primecap Management's 13F filing for Q4 2018, filed 12 Feb 2019.